- Home
- Companies
- Managed Markets Insight & Technology, ...
- Services
- MMIT - P&T Perspectives Services
MMIT - P&T Perspectives Services
Exposing potential obstacles through market research with unbiased and objective insights from P&T decision-makers is critical. MMIT P&T Perspectives provides qualitative and tangible feedback through a realistic simulated P&T session that informs your individual brand strategy and enables you to understand how your product and/or competitor’s product will fare in an actual P&T Committee review.
Predict
Predict how a P&T Committee might evaluate your drug against competitors.
Understand
Understand how pricing could impact your drug’s placement on formulary.
Identify
Identify the types of coverage restrictions that could be placed on your therapy and competitors.
Improve
Improve your drug’s launch trajectory by identifying the most competitive contracting scenarios.
MMIT's industry-leading P&T panel consists of pharmacy decision-makers at health plans, PBMs, providers and integrated delivery systems. 100% of panelists are either active P&T participants or control access for pharmaceuticals for their organizations, giving you unparalleled visibility into these entities.
Simulate
Simulate a typical payer or IDN P&T committee, including a pharmacy director, medical director, contracting executives, and physicians and disease state specialists.
Analyze
Analyze a clinical dossier developed autonomously by a clinical pharmacist, with the opportunity to provide additional clinical data and/or target product profile.
Observe
Observe a 90 minute live-streamed session, including a 45 minute clinical overview and discussion based on the clinical dossier and a 45 minute financial overview and discussion led by the contracting pharmacist.
Question
Ask specific questions of the double-blinded participants during a 15-minute Q&A session after the P&T meeting concludes.